SlideShare a Scribd company logo
Non-Invasive High Resolution Detection of
Active Atherosclerotic Plaque in ApoE
Deficient Mice by Magnetic Resonance
Imaging after Injection of Super
Paramagnetic Iron Oxide (SPIO)
Center for Vulnerable Plaque
Research
University of Texas at Houston
Texas Heart Institute
A
B
l>Macrophages
infiltration
l>Extensive angiogenesis
and vasa vasorum
leakage
Plaque Morphology
vs.
Plaque Activity
Why do we need both?
The short answer is: because not all plaques with
similar morphology would result in similar
outcome.
Morphology vs. Activity Imaging
Inactive and
non-inflamed
plaque
Active and
inflamed
plaque
Appear Similar in
IVUS OCT MRI
w/o CM
Morphology
Show Different
Activity
Thermography, Spectroscopy,
immunoscintigraphy, MRI with
targeted contrast media…
Current Methods for DetectionCurrent Methods for Detection
of Vulnerable Plaquesof Vulnerable Plaques
lOptical coherence
tomography
lRadioscintigraph
lThermography
lNear infrared
spectroscopy
lMagnetic resonance
imaging
Human Carotid Plaque
Courtesy of
Dr. Chun Yuan
University of Washington
We need MRI with vulnerable plaque
targeted contrast media that identifies:
1- Inflammation (macrophage infiltration),
2- Fissured/Permeable Cap,
3- Leaking Angiogenesis and
4- Intra-Plaque Hemorrhage
5- …
SuperparamagneticSuperparamagnetic
andand
Ultra-superparamagneticUltra-superparamagnetic
Iron OxideIron Oxide
lBlood pool Magnetic resonance (MR)
imaging contrast media with a central
core of iron oxide generally coated by a
polysaccharide layer
lShortening MR relaxation time
lEngulfed by and accumulated in cells
with phagocytic activity
Particle Core Size Particle Size Blood
(nm) (nm) Half-life
Combidex 5-6 20-30 8h
Feridex 4-6 35-50 2.4±0.2h
DDM 43/34/102 6.4 20-30 6h
Clariscan
MION 4-6 17 varies
Feruglose
--- --- --- ---
Examples of commercially available SPIOs
Current applications of SPIO in MR imaging:
-Detection of Hepatic Lesions
(primary and metastatic cancers)
-Experimental Nephritic syndrome in Laboratory animals
-Monitoring rejection of transplanted heart or kidney in
the animal model of allograft transplantation.
-Experimental detection of CNS lesions in laboratory
animals.
USPIOs Enter the AtheroscleroticUSPIOs Enter the Atherosclerotic
Plaque ThroughPlaque Through
lMacrophages that engulfed
them
lFissured or thin cap
l Extensive angiogenesis
l vasa vasorum leakage
l Intra plaque hemorrhage
In-vitro Study of Macrophage
SPIO Uptake
 In a series of in-vitro studies we have tested
the rate of SPIO uptake by human activated
monocytes in different conditions regarding
incubation time and concentration of SPIO.
All SPIO were labeled by a fluorescent dye
(DCFA).
FL-labeled SPIO Incubated Macrophages 24hr
Double DAPI Staining with Fluorescence-labeled SPIO Macrophages
after 24hr Incubation
HypothesisHypothesis
Active macrophages residing inside
the inflamed vulnerable plaques can
be visualized following injection of
SPIO or USPIOs into the systemic
circulation by virtue of a decrease in
the magnetic resonance signal
intensity of the plaque,and correlate
with histopathologic characteristics of
vulnerability to rupture.
vasa vasorum
Over magnification is a major advantage of SPIO
Darkening property of SPIO in the white background of fat
and water of plaque is another advantage
SPIO and T2 Effect
In-vitro study to show the effect of
macrophage SPIO uptake on their
T2 relaxation time
0
10
20
30
40
50
60
70
80
90
50 250 control
20 min
60 min
6 hours
24 hours
Macrophage Uptake of Feridex with Time
and Concentration Shown by T2 Reduction
Concentration µmol/ml
In-vivo distribution of SPIO in ApoE
deficient and wild type mice:
•For the initial study, we use the mouse model of
atherosclerosis.
•
•ApoE deficient mouse has similar atherosclerotic
lesions to human and the lesions are more common in
the aortic arch and thoracic aorta.
• We used ApoE deficient mice and normal variant
(C57BL mice) as control.
•The SPIO that we used was Feridex (Berlex) injectable
solution.
•Animals were sacrificed on day 3 and 5 after injection.
Pre and Post-SPIO Enhanced Magnetic
Resonance Imaging of ApoE K/O and Wild
Type Mice:
We used 4.7 tesla MRI unit (University of Texas,
Galveston MRI Unit, Galveston, TX) in our study.
After baseline MR imaging with respiratory gating, we
injected 1mMolFe/kg super paramagnetic iron oxide to
six ApoE deficient and two C57bl mice through the tail
vein.
Post-contrast MR imaging were performed in day 5 with
the same parameters (TR=2.5 sec, TE=0.012 sec,
FOV=6.6 cm, slice thickness=2.0mm, flip angle
(orient)=trans, and matrices=256x256).
We selected the aorta at the level of kidney for
comparison of the baseline and post-contrast images.
•Tissues from different organs including liver,
kidneys, lung, heart, spleen and aorta
(including valve region ascending, descending
and abdominal) was obtained and stained.
• We used Hematoxyline and Eosin (H&E), Iron,
CD68 and Movat staining.
• After Iron staining, aortic wall of the ApoE
deficient mice and normal variant were
compared based on the number of Iron
particle.
• Also different doses of Feridex and The
timing between injection and tissue obtaining
was considered.
Histopathologic study of the Mouse injected
With SPIO (Thoracic Aorta)
ApoE KO mouse, Movat staining,
proximal aorta
Coronary
Cross section
Atherosclerosis
plaque
Histopathologic study of ApoE KO Mouse injected
With SPIO (Thoracic Aorta)
CD68 staining
(aortic plaque)
Iron Staining (aortic plaque) Iron Staining (coronary section)
Iron particles Iron particles
Histopathologic study of ApoE KO Mouse
injected With SPIO (Abdominal Aorta)
H&E staining
Iron Staining CD 68 staining
Iron particles
Histopathologic study of wild type Mouse
injected With SPIO (Thoracic Aorta)
H&E staining
CD68 stainingIron staining
Comparison of the Number of the Iron Particles (per
HPF) in ApoE KO Mice Plaque vs. Normal Wall
0
5
10
15
Atherosclerotic
Aorta
Average
number of iron
particles per
sample
P <0.001
MR Image of Abdominal Aorta After SPIO
Injection in ApoE and Control Mice
ApoE
deficien
t mouse
C57B1
(control)
mouse
Before Injection After Injection (5 Days )
Dark (negatively enhanced) aortic wall, full of iron particles
Bright aortic lumen and wall without negative
enhancement and no significant number of iron particles
Typical in vivo MR images of a live mouse at the heart (left)
and renal level (right). Various vessels and aortic arch can
easily e seen in these images. The slice thickness is 0.5 mm
and the in-plane resolution is 50 µm (7.1 T MR system).
We chose Watanabe Hereditary Hypercholesterolemic rabbits (WHHR) and
New Zealand White rabbits (NZW) for this study.
We injected them with SPIO (Feridex) 1 mMol Fe/kg and obtained baseline
as well as 5-day post-SPIO injection MR images of the aorta (1.5 Tesla
MRI system at the University of Texas, MD Anderson,Houston,Texas).
Then we compared the images in hypercholesterolemic rabbits with
the normal,wild type NZW rabbits.
Rabbit ex-vivo MRI studies:
After the in-vivo MR images, we sacrificed the animals and excised the aorta.
Then we put the isolated aorta in a gel medium, clamped both ends and any
side branches and injected gadolinium inside the lumen.
We did the same procedure for all rabbits.
We also used 2 more rabbits, one WHHR and one NZW that were not injected
with SPIO, as control, in the ex-vivo MR study.
SPIO-Enhanced MRI study in rabbits
Histopathologic studies of Thoracic aorta in Watanabe
Hereditary Hypercholesterolemic rabbit after SPIO injection
H&E staining
Iron staining
Iron staining
Histopathologic studies of Thoracic aorta in Watanabe
Hereditary Hypercholesterolemic rabbit after SPIO injection
H&E staining
Iron staining Iron staining
Iron particles
Plaque Cell Density vs SPIO
0
10
20
30
40
50
60
0 10 20 30 40 50 60 70
Cell Denity in H&E staining
SPIOpositivecell-Iron
staining
Series1
R=0.956
Correlation between Iron positive cells in Iron
staining and cell density in H&E staining in rabbit
atherosclerotic aorta.
MR Angiography 3D with Gadolinium-DTPA in
Watanabe Rabbit
Before SPIO injection After SPIO injection
Ex-vivo MR study of the thoracic aorta in Watanabe and
Wild type rabbit after SPIO injection compared to control.
3D MR Angiography with Gadolinium-DTPA
Watanabe rabbit
Post-SPIO
Watanabe rabbit
control
NZW rabbit
control
NZW rabbit
Post-SPIO
Ex-vivo MR study of the thoracic aorta in Watanabe and
Wild type rabbit after SPIO injection compared to control.
(Gradient echo)
Watanabe rabbit
Post-SPIO
Watanabe rabbit
control
NZW rabbit
Post-SPIO
NZW rabbit
control

More Related Content

What's hot

Motion-Based Angiogenesis Analysis_A Simple Method to Quanitfy Blood Vessel G...
Motion-Based Angiogenesis Analysis_A Simple Method to Quanitfy Blood Vessel G...Motion-Based Angiogenesis Analysis_A Simple Method to Quanitfy Blood Vessel G...
Motion-Based Angiogenesis Analysis_A Simple Method to Quanitfy Blood Vessel G...Joe Lee
 
Sessio formacio bst terapies avancades
Sessio formacio bst terapies avancadesSessio formacio bst terapies avancades
Sessio formacio bst terapies avancades
Banc de Sang i Teixits
 
2013 Rice University Regional Undergraduate Symposium Presentation
2013 Rice University Regional Undergraduate Symposium Presentation2013 Rice University Regional Undergraduate Symposium Presentation
2013 Rice University Regional Undergraduate Symposium Presentation
Minyi Chen
 
AAOS Guidelines Infection Work-Up
AAOS Guidelines Infection Work-UpAAOS Guidelines Infection Work-Up
AAOS Guidelines Infection Work-Up
washingtonortho
 
BioCartilage Update 2013
BioCartilage Update 2013BioCartilage Update 2013
BioCartilage Update 2013
Alan M. Hirahara, M.D., FRCSC
 
Fluorescence in vivo Endomicroscopy: Imaging and Analysis (Co-Hosted w/Invicro)
Fluorescence in vivo Endomicroscopy: Imaging and Analysis (Co-Hosted w/Invicro)Fluorescence in vivo Endomicroscopy: Imaging and Analysis (Co-Hosted w/Invicro)
Fluorescence in vivo Endomicroscopy: Imaging and Analysis (Co-Hosted w/Invicro)
Scintica Instrumentation
 
Extra-cellular Matrix Patches
Extra-cellular Matrix PatchesExtra-cellular Matrix Patches
Extra-cellular Matrix Patches
Alan M. Hirahara, M.D., FRCSC
 

What's hot (8)

Stem celltherapy
Stem celltherapyStem celltherapy
Stem celltherapy
 
Motion-Based Angiogenesis Analysis_A Simple Method to Quanitfy Blood Vessel G...
Motion-Based Angiogenesis Analysis_A Simple Method to Quanitfy Blood Vessel G...Motion-Based Angiogenesis Analysis_A Simple Method to Quanitfy Blood Vessel G...
Motion-Based Angiogenesis Analysis_A Simple Method to Quanitfy Blood Vessel G...
 
Sessio formacio bst terapies avancades
Sessio formacio bst terapies avancadesSessio formacio bst terapies avancades
Sessio formacio bst terapies avancades
 
2013 Rice University Regional Undergraduate Symposium Presentation
2013 Rice University Regional Undergraduate Symposium Presentation2013 Rice University Regional Undergraduate Symposium Presentation
2013 Rice University Regional Undergraduate Symposium Presentation
 
AAOS Guidelines Infection Work-Up
AAOS Guidelines Infection Work-UpAAOS Guidelines Infection Work-Up
AAOS Guidelines Infection Work-Up
 
BioCartilage Update 2013
BioCartilage Update 2013BioCartilage Update 2013
BioCartilage Update 2013
 
Fluorescence in vivo Endomicroscopy: Imaging and Analysis (Co-Hosted w/Invicro)
Fluorescence in vivo Endomicroscopy: Imaging and Analysis (Co-Hosted w/Invicro)Fluorescence in vivo Endomicroscopy: Imaging and Analysis (Co-Hosted w/Invicro)
Fluorescence in vivo Endomicroscopy: Imaging and Analysis (Co-Hosted w/Invicro)
 
Extra-cellular Matrix Patches
Extra-cellular Matrix PatchesExtra-cellular Matrix Patches
Extra-cellular Matrix Patches
 

Viewers also liked

120 mr imaging for the evaluation of carotid atherosclerosis
120 mr imaging for the evaluation of carotid atherosclerosis120 mr imaging for the evaluation of carotid atherosclerosis
120 mr imaging for the evaluation of carotid atherosclerosis
Society for Heart Attack Prevention and Eradication
 

Viewers also liked (18)

501 autoimmune disease
501 autoimmune disease501 autoimmune disease
501 autoimmune disease
 
131 the evolution of coronary atherosclerosis
131 the evolution of coronary atherosclerosis131 the evolution of coronary atherosclerosis
131 the evolution of coronary atherosclerosis
 
Eas poster titles final
Eas poster titles finalEas poster titles final
Eas poster titles final
 
257 inhibition of atherosclerosis in mice
257 inhibition of atherosclerosis in mice257 inhibition of atherosclerosis in mice
257 inhibition of atherosclerosis in mice
 
041 transgenic cetp dahl salt sensitive (tg53) rat model
041 transgenic cetp dahl salt sensitive (tg53) rat model041 transgenic cetp dahl salt sensitive (tg53) rat model
041 transgenic cetp dahl salt sensitive (tg53) rat model
 
120 mr imaging for the evaluation of carotid atherosclerosis
120 mr imaging for the evaluation of carotid atherosclerosis120 mr imaging for the evaluation of carotid atherosclerosis
120 mr imaging for the evaluation of carotid atherosclerosis
 
042 introducing a novel model
042 introducing a novel model042 introducing a novel model
042 introducing a novel model
 
Dekorte
DekorteDekorte
Dekorte
 
Economics of screening for atherosclerosis final
Economics of screening for atherosclerosis finalEconomics of screening for atherosclerosis final
Economics of screening for atherosclerosis final
 
Deteection of vulnerable atherosclerotic plaque by nis
Deteection of vulnerable atherosclerotic plaque by nisDeteection of vulnerable atherosclerotic plaque by nis
Deteection of vulnerable atherosclerotic plaque by nis
 
036 dogs heart
036 dogs heart036 dogs heart
036 dogs heart
 
Dr koenig
Dr koenigDr koenig
Dr koenig
 
Morrisett
MorrisettMorrisett
Morrisett
 
115 genomic and proteomic screen
115 genomic and proteomic screen115 genomic and proteomic screen
115 genomic and proteomic screen
 
126 micro array study for gene expression
126 micro array study for gene expression126 micro array study for gene expression
126 micro array study for gene expression
 
105 nir spectroscopy studies
105 nir spectroscopy studies105 nir spectroscopy studies
105 nir spectroscopy studies
 
112 macrophage uptake of cns1 1 d
112 macrophage uptake of cns1 1 d112 macrophage uptake of cns1 1 d
112 macrophage uptake of cns1 1 d
 
Definition of vulnerable plaque atlanta
Definition of vulnerable plaque atlantaDefinition of vulnerable plaque atlanta
Definition of vulnerable plaque atlanta
 

Similar to 052 non invasive high resolution detection

031
031031
040 center for vulnerable plaque research
040 center for vulnerable plaque research040 center for vulnerable plaque research
040 center for vulnerable plaque research
SHAPE Society
 
051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits
SHAPE Society
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
SHAPE Society
 
053 histologic evidence of spio accumulation in vulnerable plaques
053 histologic evidence of spio accumulation in vulnerable plaques053 histologic evidence of spio accumulation in vulnerable plaques
053 histologic evidence of spio accumulation in vulnerable plaques
SHAPE Society
 
053 histologic evidence of spio accumulation in vulnerable plaques
053 histologic evidence of spio accumulation in vulnerable plaques053 histologic evidence of spio accumulation in vulnerable plaques
053 histologic evidence of spio accumulation in vulnerable plaques
Society for Heart Attack Prevention and Eradication
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
SHAPE Society
 
Non invasive detection of vulnerable plaque using spio enhanced mri
Non invasive detection of vulnerable plaque using spio enhanced mriNon invasive detection of vulnerable plaque using spio enhanced mri
Non invasive detection of vulnerable plaque using spio enhanced mri
Society for Heart Attack Prevention and Eradication
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
SHAPE Society
 
159 spio uptake by macrophages
159 spio uptake by macrophages159 spio uptake by macrophages
159 spio uptake by macrophages
SHAPE Society
 

Similar to 052 non invasive high resolution detection (20)

031
031031
031
 
040 center for vulnerable plaque research
040 center for vulnerable plaque research040 center for vulnerable plaque research
040 center for vulnerable plaque research
 
Introducing a novel model
Introducing a novel modelIntroducing a novel model
Introducing a novel model
 
Esc macrophage homing
Esc macrophage homingEsc macrophage homing
Esc macrophage homing
 
051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits
 
051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
Ricenano
RicenanoRicenano
Ricenano
 
053 histologic evidence of spio accumulation in vulnerable plaques
053 histologic evidence of spio accumulation in vulnerable plaques053 histologic evidence of spio accumulation in vulnerable plaques
053 histologic evidence of spio accumulation in vulnerable plaques
 
053 histologic evidence of spio accumulation in vulnerable plaques
053 histologic evidence of spio accumulation in vulnerable plaques053 histologic evidence of spio accumulation in vulnerable plaques
053 histologic evidence of spio accumulation in vulnerable plaques
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Plaque inflammation in atherosclerotic rabbits
Plaque inflammation in atherosclerotic rabbitsPlaque inflammation in atherosclerotic rabbits
Plaque inflammation in atherosclerotic rabbits
 
Non invasive detection of vulnerable plaque 2
Non invasive detection of vulnerable plaque 2Non invasive detection of vulnerable plaque 2
Non invasive detection of vulnerable plaque 2
 
Non invasive detection of vulnerable plaque using spio enhanced mri
Non invasive detection of vulnerable plaque using spio enhanced mriNon invasive detection of vulnerable plaque using spio enhanced mri
Non invasive detection of vulnerable plaque using spio enhanced mri
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
159 spio uptake by macrophages
159 spio uptake by macrophages159 spio uptake by macrophages
159 spio uptake by macrophages
 
159 spio uptake by macrophages
159 spio uptake by macrophages159 spio uptake by macrophages
159 spio uptake by macrophages
 

More from Society for Heart Attack Prevention and Eradication

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
Society for Heart Attack Prevention and Eradication
 

More from Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 

Recently uploaded

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 

Recently uploaded (20)

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 

052 non invasive high resolution detection

  • 1. Non-Invasive High Resolution Detection of Active Atherosclerotic Plaque in ApoE Deficient Mice by Magnetic Resonance Imaging after Injection of Super Paramagnetic Iron Oxide (SPIO) Center for Vulnerable Plaque Research University of Texas at Houston Texas Heart Institute
  • 2. A B
  • 4. Plaque Morphology vs. Plaque Activity Why do we need both? The short answer is: because not all plaques with similar morphology would result in similar outcome.
  • 5. Morphology vs. Activity Imaging Inactive and non-inflamed plaque Active and inflamed plaque Appear Similar in IVUS OCT MRI w/o CM Morphology Show Different Activity Thermography, Spectroscopy, immunoscintigraphy, MRI with targeted contrast media…
  • 6. Current Methods for DetectionCurrent Methods for Detection of Vulnerable Plaquesof Vulnerable Plaques lOptical coherence tomography lRadioscintigraph lThermography lNear infrared spectroscopy lMagnetic resonance imaging
  • 7. Human Carotid Plaque Courtesy of Dr. Chun Yuan University of Washington
  • 8. We need MRI with vulnerable plaque targeted contrast media that identifies: 1- Inflammation (macrophage infiltration), 2- Fissured/Permeable Cap, 3- Leaking Angiogenesis and 4- Intra-Plaque Hemorrhage 5- …
  • 9. SuperparamagneticSuperparamagnetic andand Ultra-superparamagneticUltra-superparamagnetic Iron OxideIron Oxide lBlood pool Magnetic resonance (MR) imaging contrast media with a central core of iron oxide generally coated by a polysaccharide layer lShortening MR relaxation time lEngulfed by and accumulated in cells with phagocytic activity
  • 10. Particle Core Size Particle Size Blood (nm) (nm) Half-life Combidex 5-6 20-30 8h Feridex 4-6 35-50 2.4±0.2h DDM 43/34/102 6.4 20-30 6h Clariscan MION 4-6 17 varies Feruglose --- --- --- --- Examples of commercially available SPIOs
  • 11. Current applications of SPIO in MR imaging: -Detection of Hepatic Lesions (primary and metastatic cancers) -Experimental Nephritic syndrome in Laboratory animals -Monitoring rejection of transplanted heart or kidney in the animal model of allograft transplantation. -Experimental detection of CNS lesions in laboratory animals.
  • 12. USPIOs Enter the AtheroscleroticUSPIOs Enter the Atherosclerotic Plaque ThroughPlaque Through lMacrophages that engulfed them lFissured or thin cap l Extensive angiogenesis l vasa vasorum leakage l Intra plaque hemorrhage
  • 13. In-vitro Study of Macrophage SPIO Uptake  In a series of in-vitro studies we have tested the rate of SPIO uptake by human activated monocytes in different conditions regarding incubation time and concentration of SPIO. All SPIO were labeled by a fluorescent dye (DCFA).
  • 14. FL-labeled SPIO Incubated Macrophages 24hr
  • 15. Double DAPI Staining with Fluorescence-labeled SPIO Macrophages after 24hr Incubation
  • 16. HypothesisHypothesis Active macrophages residing inside the inflamed vulnerable plaques can be visualized following injection of SPIO or USPIOs into the systemic circulation by virtue of a decrease in the magnetic resonance signal intensity of the plaque,and correlate with histopathologic characteristics of vulnerability to rupture.
  • 17. vasa vasorum Over magnification is a major advantage of SPIO Darkening property of SPIO in the white background of fat and water of plaque is another advantage
  • 18. SPIO and T2 Effect In-vitro study to show the effect of macrophage SPIO uptake on their T2 relaxation time
  • 19.
  • 20. 0 10 20 30 40 50 60 70 80 90 50 250 control 20 min 60 min 6 hours 24 hours Macrophage Uptake of Feridex with Time and Concentration Shown by T2 Reduction Concentration µmol/ml
  • 21. In-vivo distribution of SPIO in ApoE deficient and wild type mice: •For the initial study, we use the mouse model of atherosclerosis. • •ApoE deficient mouse has similar atherosclerotic lesions to human and the lesions are more common in the aortic arch and thoracic aorta. • We used ApoE deficient mice and normal variant (C57BL mice) as control. •The SPIO that we used was Feridex (Berlex) injectable solution. •Animals were sacrificed on day 3 and 5 after injection.
  • 22. Pre and Post-SPIO Enhanced Magnetic Resonance Imaging of ApoE K/O and Wild Type Mice: We used 4.7 tesla MRI unit (University of Texas, Galveston MRI Unit, Galveston, TX) in our study. After baseline MR imaging with respiratory gating, we injected 1mMolFe/kg super paramagnetic iron oxide to six ApoE deficient and two C57bl mice through the tail vein. Post-contrast MR imaging were performed in day 5 with the same parameters (TR=2.5 sec, TE=0.012 sec, FOV=6.6 cm, slice thickness=2.0mm, flip angle (orient)=trans, and matrices=256x256). We selected the aorta at the level of kidney for comparison of the baseline and post-contrast images.
  • 23. •Tissues from different organs including liver, kidneys, lung, heart, spleen and aorta (including valve region ascending, descending and abdominal) was obtained and stained. • We used Hematoxyline and Eosin (H&E), Iron, CD68 and Movat staining. • After Iron staining, aortic wall of the ApoE deficient mice and normal variant were compared based on the number of Iron particle. • Also different doses of Feridex and The timing between injection and tissue obtaining was considered.
  • 24. Histopathologic study of the Mouse injected With SPIO (Thoracic Aorta) ApoE KO mouse, Movat staining, proximal aorta Coronary Cross section Atherosclerosis plaque
  • 25. Histopathologic study of ApoE KO Mouse injected With SPIO (Thoracic Aorta) CD68 staining (aortic plaque) Iron Staining (aortic plaque) Iron Staining (coronary section) Iron particles Iron particles
  • 26. Histopathologic study of ApoE KO Mouse injected With SPIO (Abdominal Aorta) H&E staining Iron Staining CD 68 staining Iron particles
  • 27. Histopathologic study of wild type Mouse injected With SPIO (Thoracic Aorta) H&E staining CD68 stainingIron staining
  • 28. Comparison of the Number of the Iron Particles (per HPF) in ApoE KO Mice Plaque vs. Normal Wall 0 5 10 15 Atherosclerotic Aorta Average number of iron particles per sample P <0.001
  • 29. MR Image of Abdominal Aorta After SPIO Injection in ApoE and Control Mice ApoE deficien t mouse C57B1 (control) mouse Before Injection After Injection (5 Days ) Dark (negatively enhanced) aortic wall, full of iron particles Bright aortic lumen and wall without negative enhancement and no significant number of iron particles
  • 30. Typical in vivo MR images of a live mouse at the heart (left) and renal level (right). Various vessels and aortic arch can easily e seen in these images. The slice thickness is 0.5 mm and the in-plane resolution is 50 µm (7.1 T MR system).
  • 31. We chose Watanabe Hereditary Hypercholesterolemic rabbits (WHHR) and New Zealand White rabbits (NZW) for this study. We injected them with SPIO (Feridex) 1 mMol Fe/kg and obtained baseline as well as 5-day post-SPIO injection MR images of the aorta (1.5 Tesla MRI system at the University of Texas, MD Anderson,Houston,Texas). Then we compared the images in hypercholesterolemic rabbits with the normal,wild type NZW rabbits. Rabbit ex-vivo MRI studies: After the in-vivo MR images, we sacrificed the animals and excised the aorta. Then we put the isolated aorta in a gel medium, clamped both ends and any side branches and injected gadolinium inside the lumen. We did the same procedure for all rabbits. We also used 2 more rabbits, one WHHR and one NZW that were not injected with SPIO, as control, in the ex-vivo MR study. SPIO-Enhanced MRI study in rabbits
  • 32. Histopathologic studies of Thoracic aorta in Watanabe Hereditary Hypercholesterolemic rabbit after SPIO injection H&E staining Iron staining Iron staining
  • 33. Histopathologic studies of Thoracic aorta in Watanabe Hereditary Hypercholesterolemic rabbit after SPIO injection H&E staining Iron staining Iron staining Iron particles
  • 34. Plaque Cell Density vs SPIO 0 10 20 30 40 50 60 0 10 20 30 40 50 60 70 Cell Denity in H&E staining SPIOpositivecell-Iron staining Series1 R=0.956 Correlation between Iron positive cells in Iron staining and cell density in H&E staining in rabbit atherosclerotic aorta.
  • 35. MR Angiography 3D with Gadolinium-DTPA in Watanabe Rabbit Before SPIO injection After SPIO injection
  • 36. Ex-vivo MR study of the thoracic aorta in Watanabe and Wild type rabbit after SPIO injection compared to control. 3D MR Angiography with Gadolinium-DTPA Watanabe rabbit Post-SPIO Watanabe rabbit control NZW rabbit control NZW rabbit Post-SPIO
  • 37. Ex-vivo MR study of the thoracic aorta in Watanabe and Wild type rabbit after SPIO injection compared to control. (Gradient echo) Watanabe rabbit Post-SPIO Watanabe rabbit control NZW rabbit Post-SPIO NZW rabbit control